Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Gross Margin (2020 - 2025)

Historic Gross Margin for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to 970.34%.

  • iSpecimen's Gross Margin fell 10119600.0% to 970.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.38%, marking a year-over-year decrease of 543500.0%. This contributed to the annual value of 42.93% for FY2024, which is 85200.0% down from last year.
  • According to the latest figures from Q3 2025, iSpecimen's Gross Margin is 970.34%, which was down 10119600.0% from 37.71% recorded in Q2 2025.
  • iSpecimen's 5-year Gross Margin high stood at 66.39% for Q3 2021, and its period low was 970.34% during Q3 2025.
  • Over the past 5 years, iSpecimen's median Gross Margin value was 49.87% (recorded in 2023), while the average stood at 5.84%.
  • Its Gross Margin has fluctuated over the past 5 years, first skyrocketed by 104200bps in 2024, then tumbled by -10119600bps in 2025.
  • iSpecimen's Gross Margin (Quarter) stood at 52.05% in 2021, then increased by 1bps to 52.4% in 2022, then dropped by -15bps to 44.58% in 2023, then crashed by -77bps to 10.26% in 2024, then crashed by -9560bps to 970.34% in 2025.
  • Its Gross Margin stands at 970.34% for Q3 2025, versus 37.71% for Q2 2025 and 37.85% for Q1 2025.